Cellectar Biosciences, Inc.
Why Is Cellectar Biosciences, Inc. (CLRB) Stock Down Today?
Live update on CLRB's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Summary
Cellectar Biosciences, Inc. (CLRB) is trading down -5.58% at $0.41, reflecting a negative shift in investor sentiment today. The stock opened at $0.43 and has moved between $0.41 and $0.45 so far.
Trading volume is 2556222, which is 79% below its average, and the price action suggests selling interest.
Technically, CLRB is trading above its 50-day moving average of $0.29 and below its 200-day moving average of $0.92, indicating short-term strength but long-term weakness.
The average 1-year price target is $12.00. Meyka's AI assigns CLRB a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -209.06% in 1 month (-$0.45), -15.85% in 1 year ($0.35), and -56.90% in 5 years ($0.18).
In context, the broader Healthcare sector is down -3.60% today, which may be contributing to the move.
View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.
CLRB Technical Signals
Trading over 50-day moving average ($0.29)
Trading below 200-day moving average ($0.92)
Analyst Recommendations
Price Targets
Sector Context
The Healthcare sector is down -3.60% today, with the Biotechnology industry contributing to the decline. This broader context may be weighing on the stock's performance.
Price Forecast
1 Month
$-0.45
1 Year
$0.35
3 Years
$0.20
5 Years
$0.18
Is this change significant?
5-Day:-5.93%
1-Month:-13.42%
3-Month:-3.37%
What's next?
Next earnings date: 7/30/2025